These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18815048)

  • 1. Knowledgebase for addiction-related genes: is it possible an extrapolation to rational multi-target drug design?
    Espinoza-Fonseca LM
    Bioorg Med Chem; 2008 Oct; 16(20):9346-8. PubMed ID: 18815048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The multi-target drugs and their design].
    Jiang FC
    Yao Xue Xue Bao; 2009 Mar; 44(3):282-7. PubMed ID: 19449525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of multi-target drugs: the network approach might help drug design.
    Csermely P; Agoston V; Pongor S
    Trends Pharmacol Sci; 2005 Apr; 26(4):178-82. PubMed ID: 15808341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based drug design: combining philosophy with technology.
    Bartoli S; Fincham CI; Fattori D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):422-9. PubMed ID: 17659483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing combinatorial libraries optimized on multiple objectives.
    Gillet VJ
    Methods Mol Biol; 2004; 275():335-54. PubMed ID: 15141120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity-oriented synthesis: exploring the intersections between chemistry and biology.
    Tan DS
    Nat Chem Biol; 2005 Jul; 1(2):74-84. PubMed ID: 16408003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target therapeutics: when the whole is greater than the sum of the parts.
    Zimmermann GR; Lehár J; Keith CT
    Drug Discov Today; 2007 Jan; 12(1-2):34-42. PubMed ID: 17198971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we rationally design promiscuous drugs?
    Hopkins AL; Mason JS; Overington JP
    Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of the multi-target approach in drug design and discovery.
    Espinoza-Fonseca LM
    Bioorg Med Chem; 2006 Feb; 14(4):896-7. PubMed ID: 16203151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2008 Nov; 8(6):689-95. PubMed ID: 18999921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation chemical proteomic tools for rapid enzyme profiling.
    Uttamchandani M; Lu CH; Yao SQ
    Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering and its application in multi-target prediction.
    Liu W; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to design multi-target drugs.
    Korcsmáros T; Szalay MS; Böde C; Kovács IA; Csermely P
    Expert Opin Drug Discov; 2007 Jun; 2(6):799-808. PubMed ID: 23488998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.
    Park K; Lee S; Ahn HS; Kim D
    Mol Biosyst; 2009 Aug; 5(8):844-53. PubMed ID: 19603120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network pharmacology: the next paradigm in drug discovery.
    Hopkins AL
    Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity-oriented fluorescence library approach for the discovery of sensors and probes.
    Lee JS; Kim YK; Vendrell M; Chang YT
    Mol Biosyst; 2009 May; 5(5):411-21. PubMed ID: 19381357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular underpinnings of the targeted therapy for cancer.
    Wcisło G
    Acta Pol Pharm; 2008; 65(6):633-40. PubMed ID: 19172844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.